Promising hantavirus vaccine research stalled by funding gap before outbreak
Research on a promising hantavirus vaccine has been delayed due to a lack of funding. This comes in light of renewed global concern following a recent outbreak on a cruise ship. Authorities are preparing quarantine measures in response to the situation.
- ▪Early results for a hantavirus vaccine showed promise but are currently stalled.
- ▪The funding gap has hindered further development of the vaccine.
- ▪A recent outbreak on the cruise ship MV Hondius has raised global concerns about hantavirus.
Jerusalem Post publishes from Israel and files mainly under world. We currently carry 1,303 of its stories.
Opening excerpt (first ~120 words) tap to expand
Promising hantavirus vaccine research stalled by funding gap before outbreak Promising early results have been put on the back burner despite renewed global concern following a deadly cruise ship outbreak. Follow us on GoogleMedics work outside of the cruise ship MV Hondius, which was affected by a hantavirus outbreak, after it arrived at the Port of Rotterdam, where Dutch authorities are preparing quarantine arrangements, in Rotterdam, Netherlands, May 18, 2026.(photo credit: YVES HERMAN/REUTERS)
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Jerusalem Post | JPost.com.